Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GlaxoSmithKline Pharmaceuticals Limited
No Price
Closing Price XNSE 29.04.2026:
2.364,00 INR
29.04.2026 09:53
Current Prices from GlaxoSmithKline Pharmaceuticals Limited
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NSE
GLAXO.NS
INR
29.04.2026 09:53
2.364,00 INR
-41,15 INR
-1,71 %
MSE
GLAXO.BO
INR
29.04.2026 09:37
2.377,00 INR
-28,15 INR
-1,17 %
Share Float & Liquidity
Free Float24,35 %
Shares Float41,25 M
Shares Outstanding169,41 M
Company Profile for GlaxoSmithKline Pharmaceuticals Limited Share
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.
